Gå offline med appen Player FM !
Where is the latest innovation in neuroscience?
Manage episode 390603903 series 1919400
This is the latest episode of the free DDW narrated podcast, titled “Where is the latest innovation in neuroscience?” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: "Taking a new approach to tackle neurodegenerative diseases", " The rise of digital biomarkers in neuroscience drug development", and "Keeping technology at the front of neuroscience research".
In the first article, William Erhardt, President, Head of Development & Operations of biotech Oligomerix, tells Lu Rahman about the company’s differentiated approach to developing disease-modifying therapeutics for neurodegenerative diseases.
In the second article, Dr J Mark Treherne, Dr Jenny Barnett and Dr Paula Moran answer the question of whether an expansion in the use of effective digital biomarkers will help improve the productivity of drug development in neuroscience.
In the third article, David Gray, CSO of Inscopix talks to Lu Rahman about the company’s understanding of the neuroscience market and its quest to improve technologies for neuroscientists to enable multimodal research.
You can also find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
153 episoder
Manage episode 390603903 series 1919400
This is the latest episode of the free DDW narrated podcast, titled “Where is the latest innovation in neuroscience?” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: "Taking a new approach to tackle neurodegenerative diseases", " The rise of digital biomarkers in neuroscience drug development", and "Keeping technology at the front of neuroscience research".
In the first article, William Erhardt, President, Head of Development & Operations of biotech Oligomerix, tells Lu Rahman about the company’s differentiated approach to developing disease-modifying therapeutics for neurodegenerative diseases.
In the second article, Dr J Mark Treherne, Dr Jenny Barnett and Dr Paula Moran answer the question of whether an expansion in the use of effective digital biomarkers will help improve the productivity of drug development in neuroscience.
In the third article, David Gray, CSO of Inscopix talks to Lu Rahman about the company’s understanding of the neuroscience market and its quest to improve technologies for neuroscientists to enable multimodal research.
You can also find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
153 episoder
Alla avsnitt
×Välkommen till Player FM
Player FM scannar webben för högkvalitativa podcasts för dig att njuta av nu direkt. Den är den bästa podcast-appen och den fungerar med Android, Iphone och webben. Bli medlem för att synka prenumerationer mellan enheter.